Loading…
P278 Feasibility study of adjuvant fluorouracil/epirubicin/cyclophosphamide (FEC 100) followed by triweekly docetaxel (D) plus trastuzumab (H) in HER2/neu positive early breast cancer
Saved in:
Published in: | Breast (Edinburgh) 2011, Vol.20, p.S66-S67 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 0960-9776 1532-3080 |
DOI: | 10.1016/S0960-9776(11)70220-X |